August 21, 2020 C-Path’s PKDOC and The PKD Foundation Set to Collaborate Once Again Polycystic Kidney Disease (PKD) is an inherited disorder in which clusters of cysts develop in the kidneys. There are more than 20
August 14, 2020 ePRO Consortium Announces Publication of Open Access Article C-Path’s ePRO Consortium is pleased to announce that “Demystifying Submissions of eCOA Documentation for Ethics
July 30, 2020 C-Path Partners with CHDR to Expand Global Collaborations The Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for b
June 11, 2020 From the Regulatory Affairs Professional Society (RAPS): FDA’s CURE ID app gets a COVID-19 refresh An online case reporting platform has been optimized for COVID-19 and will be the springboard for a new public-private drug
April 10, 2020 ePRO Consortium Announces COVID-19 Risk Assessment and Mitigation Strategies for Sponsors and eCOA Providers for Collection of PRO Data through Clinical Sites In collaboration with C-Path’s PRO Consortium, the ePRO Consortium has developed the presentation titled “Coronavirus D
March 26, 2020 ePRO Consortium Announces Open Access Article In collaboration with the DIA Study Endpoints Community, C-Path’s ePRO Consortium is pleased to announce the open
December 2, 2019 Workshop Summary, Advancing the Development and Implementation of Analysis Data Standards, Now Available C-Path is proud to announce the availability of the workshop summary, Advancing the Development and Implementation of Analysis Dat
October 29, 2019 U.S. Senator Martha McSally Visits C-Path U.S. Senator Martha McSally (Arizona) visited Tucson-based Critical Path Institute (C-Path) Friday, October 25, to learn more abou
September 30, 2019 The Critical Path for Parkinson’s Consortium (CPP) welcomes PMD Alliance as newest member The Critical Path for Parkinson’s Consortium (CPP) is thrilled to welcome the PMD Alliance (Parkinson & Movement Disorder Al
August 12, 2019 C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting